세계의 아포모르핀 염산염 : 시장 점유율과 순위, 전체 판매량 및 수요 예측(2025-2031년)

The global market for Apomorphine Hydrochloride was estimated to be worth US$ 150 million in 2024 and is forecast to a readjusted size of US$ 209 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Apomorphine Hydrochloride cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Apomorphine is a non-selective dopamine agonist which activates both D2-like and, to a much lesser extent, D1-like receptors. It also acts as an antagonist of 5-HT2 and a-adrenergic receptors with high affinity. The compound is historically a morphine decomposition product made by boiling morphine with concentrated acid, hence the -morphine suffix. Apomorphine does not actually contain morphine or its skeleton, nor does it bind to opioid receptors.

The classification of Apomorphine Hydrochloride includes Injection, Tablets, Thinfilm, etc and the proportion of Injection in 2019 is about 89.88%, and the proportion is in decreasing trend from 2020 to 2025. Apomorphine Hydrochloride is widely used through Parkinson Disease and Erectile Dysfunction. The most proportion of Apomorphine Hydrochloride is used for Parkinson Disease, and the sales proportion in 2019 is 89.88%. Europe is the largest consumption place, with a consumption market share nearly 54.19% in 2019. Following Europe, North America is the second largest consumption place with the consumption market share of 23.69%. Market competition is not intense. Supernus Pharmaceuticals, Britannia Pharmaceuticals STADA, Ever Pharma are the leaders of the industry, and they hold key technologies and patents, with high-end customers.

This report aims to provide a comprehensive presentation of the global market for Apomorphine Hydrochloride, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Apomorphine Hydrochloride by region & country, by Type, and by Application.

The Apomorphine Hydrochloride market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Apomorphine Hydrochloride.

Market Segmentation

By Company

• Supernus Pharmaceuticals
• Britannia Pharmaceuticals STADA
• Ever Pharma
• Evolan Pharma AB (PharmSwed)
• Tianjin Tianwei Pharmaceutical
• Sunovion
• STADA Arzneimittel
• Aguettant
• Italfarmaco
• Sumitomo Pharma
• Hubei Keyi Pharma

Segment by Type

• Injection
• Tablets
• Thinfilm
• Nasal Powder (Pipeline)

Segment by Application

• Parkinson Disease
• Erectile Dysfunction

By Region

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Netherlands
  • Nordic Countries
  • Rest of Europe
• Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Apomorphine Hydrochloride manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Apomorphine Hydrochloride in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Apomorphine Hydrochloride in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 Apomorphine Hydrochloride Product Introduction
• 1.2 Global Apomorphine Hydrochloride Market Size Forecast
  • 1.2.1 Global Apomorphine Hydrochloride Sales Value (2020-2031)
  • 1.2.2 Global Apomorphine Hydrochloride Sales Volume (2020-2031)
  • 1.2.3 Global Apomorphine Hydrochloride Sales Price (2020-2031)
• 1.3 Apomorphine Hydrochloride Market Trends & Drivers
  • 1.3.1 Apomorphine Hydrochloride Industry Trends
  • 1.3.2 Apomorphine Hydrochloride Market Drivers & Opportunity
  • 1.3.3 Apomorphine Hydrochloride Market Challenges
  • 1.3.4 Apomorphine Hydrochloride Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Apomorphine Hydrochloride Players Revenue Ranking (2024)
• 2.2 Global Apomorphine Hydrochloride Revenue by Company (2020-2025)
• 2.3 Global Apomorphine Hydrochloride Players Sales Volume Ranking (2024)
• 2.4 Global Apomorphine Hydrochloride Sales Volume by Company Players (2020-2025)
• 2.5 Global Apomorphine Hydrochloride Average Price by Company (2020-2025)
• 2.6 Key Manufacturers Apomorphine Hydrochloride Manufacturing Base and Headquarters
• 2.7 Key Manufacturers Apomorphine Hydrochloride Product Offered
• 2.8 Key Manufacturers Time to Begin Mass Production of Apomorphine Hydrochloride
• 2.9 Apomorphine Hydrochloride Market Competitive Analysis
  • 2.9.1 Apomorphine Hydrochloride Market Concentration Rate (2020-2025)
  • 2.9.2 Global 5 and 10 Largest Manufacturers by Apomorphine Hydrochloride Revenue in 2024
  • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Apomorphine Hydrochloride as of 2024)
• 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 Injection
  • 3.1.2 Tablets
  • 3.1.3 Thinfilm
  • 3.1.4 Nasal Powder (Pipeline)
• 3.2 Global Apomorphine Hydrochloride Sales Value by Type
  • 3.2.1 Global Apomorphine Hydrochloride Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global Apomorphine Hydrochloride Sales Value, by Type (2020-2031)
  • 3.2.3 Global Apomorphine Hydrochloride Sales Value, by Type (%) (2020-2031)
• 3.3 Global Apomorphine Hydrochloride Sales Volume by Type
  • 3.3.1 Global Apomorphine Hydrochloride Sales Volume by Type (2020 VS 2024 VS 2031)
  • 3.3.2 Global Apomorphine Hydrochloride Sales Volume, by Type (2020-2031)
  • 3.3.3 Global Apomorphine Hydrochloride Sales Volume, by Type (%) (2020-2031)
• 3.4 Global Apomorphine Hydrochloride Average Price by Type (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Parkinson Disease
  • 4.1.2 Erectile Dysfunction
• 4.2 Global Apomorphine Hydrochloride Sales Value by Application
  • 4.2.1 Global Apomorphine Hydrochloride Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global Apomorphine Hydrochloride Sales Value, by Application (2020-2031)
  • 4.2.3 Global Apomorphine Hydrochloride Sales Value, by Application (%) (2020-2031)
• 4.3 Global Apomorphine Hydrochloride Sales Volume by Application
  • 4.3.1 Global Apomorphine Hydrochloride Sales Volume by Application (2020 VS 2024 VS 2031)
  • 4.3.2 Global Apomorphine Hydrochloride Sales Volume, by Application (2020-2031)
  • 4.3.3 Global Apomorphine Hydrochloride Sales Volume, by Application (%) (2020-2031)
• 4.4 Global Apomorphine Hydrochloride Average Price by Application (2020-2031)

5 Segmentation by Region

• 5.1 Global Apomorphine Hydrochloride Sales Value by Region
  • 5.1.1 Global Apomorphine Hydrochloride Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global Apomorphine Hydrochloride Sales Value by Region (2020-2025)
  • 5.1.3 Global Apomorphine Hydrochloride Sales Value by Region (2026-2031)
  • 5.1.4 Global Apomorphine Hydrochloride Sales Value by Region (%), (2020-2031)
• 5.2 Global Apomorphine Hydrochloride Sales Volume by Region
  • 5.2.1 Global Apomorphine Hydrochloride Sales Volume by Region: 2020 VS 2024 VS 2031
  • 5.2.2 Global Apomorphine Hydrochloride Sales Volume by Region (2020-2025)
  • 5.2.3 Global Apomorphine Hydrochloride Sales Volume by Region (2026-2031)
  • 5.2.4 Global Apomorphine Hydrochloride Sales Volume by Region (%), (2020-2031)
• 5.3 Global Apomorphine Hydrochloride Average Price by Region (2020-2031)
• 5.4 North America
  • 5.4.1 North America Apomorphine Hydrochloride Sales Value, 2020-2031
  • 5.4.2 North America Apomorphine Hydrochloride Sales Value by Country (%), 2024 VS 2031
• 5.5 Europe
  • 5.5.1 Europe Apomorphine Hydrochloride Sales Value, 2020-2031
  • 5.5.2 Europe Apomorphine Hydrochloride Sales Value by Country (%), 2024 VS 2031
• 5.6 Asia Pacific
  • 5.6.1 Asia Pacific Apomorphine Hydrochloride Sales Value, 2020-2031
  • 5.6.2 Asia Pacific Apomorphine Hydrochloride Sales Value by Region (%), 2024 VS 2031
• 5.7 South America
  • 5.7.1 South America Apomorphine Hydrochloride Sales Value, 2020-2031
  • 5.7.2 South America Apomorphine Hydrochloride Sales Value by Country (%), 2024 VS 2031
• 5.8 Middle East & Africa
  • 5.8.1 Middle East & Africa Apomorphine Hydrochloride Sales Value, 2020-2031
  • 5.8.2 Middle East & Africa Apomorphine Hydrochloride Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Apomorphine Hydrochloride Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions Apomorphine Hydrochloride Sales Value and Sales Volume
  • 6.2.1 Key Countries/Regions Apomorphine Hydrochloride Sales Value, 2020-2031
  • 6.2.2 Key Countries/Regions Apomorphine Hydrochloride Sales Volume, 2020-2031
• 6.3 United States
  • 6.3.1 United States Apomorphine Hydrochloride Sales Value, 2020-2031
  • 6.3.2 United States Apomorphine Hydrochloride Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States Apomorphine Hydrochloride Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe Apomorphine Hydrochloride Sales Value, 2020-2031
  • 6.4.2 Europe Apomorphine Hydrochloride Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe Apomorphine Hydrochloride Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China Apomorphine Hydrochloride Sales Value, 2020-2031
  • 6.5.2 China Apomorphine Hydrochloride Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China Apomorphine Hydrochloride Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan Apomorphine Hydrochloride Sales Value, 2020-2031
  • 6.6.2 Japan Apomorphine Hydrochloride Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan Apomorphine Hydrochloride Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea Apomorphine Hydrochloride Sales Value, 2020-2031
  • 6.7.2 South Korea Apomorphine Hydrochloride Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea Apomorphine Hydrochloride Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia Apomorphine Hydrochloride Sales Value, 2020-2031
  • 6.8.2 Southeast Asia Apomorphine Hydrochloride Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia Apomorphine Hydrochloride Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India Apomorphine Hydrochloride Sales Value, 2020-2031
  • 6.9.2 India Apomorphine Hydrochloride Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India Apomorphine Hydrochloride Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 Supernus Pharmaceuticals
  • 7.1.1 Supernus Pharmaceuticals Company Information
  • 7.1.2 Supernus Pharmaceuticals Introduction and Business Overview
  • 7.1.3 Supernus Pharmaceuticals Apomorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.1.4 Supernus Pharmaceuticals Apomorphine Hydrochloride Product Offerings
  • 7.1.5 Supernus Pharmaceuticals Recent Development
• 7.2 Britannia Pharmaceuticals STADA
  • 7.2.1 Britannia Pharmaceuticals STADA Company Information
  • 7.2.2 Britannia Pharmaceuticals STADA Introduction and Business Overview
  • 7.2.3 Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.2.4 Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Product Offerings
  • 7.2.5 Britannia Pharmaceuticals STADA Recent Development
• 7.3 Ever Pharma
  • 7.3.1 Ever Pharma Company Information
  • 7.3.2 Ever Pharma Introduction and Business Overview
  • 7.3.3 Ever Pharma Apomorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.3.4 Ever Pharma Apomorphine Hydrochloride Product Offerings
  • 7.3.5 Ever Pharma Recent Development
• 7.4 Evolan Pharma AB (PharmSwed)
  • 7.4.1 Evolan Pharma AB (PharmSwed) Company Information
  • 7.4.2 Evolan Pharma AB (PharmSwed) Introduction and Business Overview
  • 7.4.3 Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.4.4 Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Product Offerings
  • 7.4.5 Evolan Pharma AB (PharmSwed) Recent Development
• 7.5 Tianjin Tianwei Pharmaceutical
  • 7.5.1 Tianjin Tianwei Pharmaceutical Company Information
  • 7.5.2 Tianjin Tianwei Pharmaceutical Introduction and Business Overview
  • 7.5.3 Tianjin Tianwei Pharmaceutical Apomorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.5.4 Tianjin Tianwei Pharmaceutical Apomorphine Hydrochloride Product Offerings
  • 7.5.5 Tianjin Tianwei Pharmaceutical Recent Development
• 7.6 Sunovion
  • 7.6.1 Sunovion Company Information
  • 7.6.2 Sunovion Introduction and Business Overview
  • 7.6.3 Sunovion Apomorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.6.4 Sunovion Apomorphine Hydrochloride Product Offerings
  • 7.6.5 Sunovion Recent Development
• 7.7 STADA Arzneimittel
  • 7.7.1 STADA Arzneimittel Company Information
  • 7.7.2 STADA Arzneimittel Introduction and Business Overview
  • 7.7.3 STADA Arzneimittel Apomorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.7.4 STADA Arzneimittel Apomorphine Hydrochloride Product Offerings
  • 7.7.5 STADA Arzneimittel Recent Development
• 7.8 Aguettant
  • 7.8.1 Aguettant Company Information
  • 7.8.2 Aguettant Introduction and Business Overview
  • 7.8.3 Aguettant Apomorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.8.4 Aguettant Apomorphine Hydrochloride Product Offerings
  • 7.8.5 Aguettant Recent Development
• 7.9 Italfarmaco
  • 7.9.1 Italfarmaco Company Information
  • 7.9.2 Italfarmaco Introduction and Business Overview
  • 7.9.3 Italfarmaco Apomorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.9.4 Italfarmaco Apomorphine Hydrochloride Product Offerings
  • 7.9.5 Italfarmaco Recent Development
• 7.10 Sumitomo Pharma
  • 7.10.1 Sumitomo Pharma Company Information
  • 7.10.2 Sumitomo Pharma Introduction and Business Overview
  • 7.10.3 Sumitomo Pharma Apomorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.10.4 Sumitomo Pharma Apomorphine Hydrochloride Product Offerings
  • 7.10.5 Sumitomo Pharma Recent Development
• 7.11 Hubei Keyi Pharma
  • 7.11.1 Hubei Keyi Pharma Company Information
  • 7.11.2 Hubei Keyi Pharma Introduction and Business Overview
  • 7.11.3 Hubei Keyi Pharma Apomorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.11.4 Hubei Keyi Pharma Apomorphine Hydrochloride Product Offerings
  • 7.11.5 Hubei Keyi Pharma Recent Development

8 Industry Chain Analysis

• 8.1 Apomorphine Hydrochloride Industrial Chain
• 8.2 Apomorphine Hydrochloride Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 Apomorphine Hydrochloride Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 Apomorphine Hydrochloride Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer